166 results
8-K
EX-99.1
BIIB
Biogen Inc
24 Apr 24
First quarter revenue $2.3 billion; GAAP diluted EPS $2.70; Non-GAAP diluted EPS $3.67
7:02am
costs, retention bonuses, facility closing and exit costs, asset impairment charges or additional depreciation when the expected useful life of certain
8-K
EX-99.1
cawev ds39sshjj57eiu
13 Feb 24
Biogen reports fourth quarter and full year 2023 results and expects return to Non-GAAP EPS growth in 2024
7:07am
8-K
EX-99.1
s9is0nt4o cvdsh
8 Nov 23
Biogen reports third quarter 2023 results and updates full year 2023 guidance
7:02am
8-K
EX-10.1
037tn9r jhm3ua
1 Sep 23
Entry into a Material Definitive Agreement
4:36pm
DEFA14A
yztuf5odvp3felzm
31 Jul 23
Additional proxy soliciting materials
7:02am
8-K
EX-2.1
m2f tuwy53ek6qgt4z
31 Jul 23
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.1
exr63 46jj
25 Jul 23
Second quarter revenue $2,456 million; GAAP diluted EPS $4.07; Non-GAAP diluted EPS $4.02
7:03am
8-K
EX-99.1
j0uq k1799g0buqi93
25 Apr 23
Company reports first quarter 2023 results and reaffirms full year 2023 guidance
7:02am
8-K
EX-10.1
10x2ag1lcra3f 4s577
10 Nov 22
Biogen Names Christopher Viehbacher President and Chief Executive Officer
7:26am
8-K
EX-99.1
uwfg8xqz0
25 Oct 22
Biogen Reports Third Quarter 2022 Results
7:08am